...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Treatment with Ginger Ameliorates Fructose-Induced Fatty Liver and Hypertriglyceridemia in Rats: Modulation of the Hepatic Carbohydrate Response Element-Binding Protein-Mediated Pathway
【24h】

Treatment with Ginger Ameliorates Fructose-Induced Fatty Liver and Hypertriglyceridemia in Rats: Modulation of the Hepatic Carbohydrate Response Element-Binding Protein-Mediated Pathway

机译:生姜治疗可改善果糖诱导的大鼠脂肪肝和高甘油三酯血症:肝碳水化合物反应元素结合蛋白介导的途径的调节。

获取原文
           

摘要

Ginger has been demonstrated to improve lipid derangements. However, its underlying triglyceride-lowering mechanisms remain unclear. Fructose overconsumption is associated with increase in hepatic de novo lipogenesis, thereby resulting in lipid derangements. Here we found that coadministration of the alcoholic extract of ginger (50 mg/kg/day, oral gavage, once daily) over 5 weeks reversed liquid fructose-induced increase in plasma triglyceride and glucose concentrations and hepatic triglyceride content in rats. Plasma nonesterified fatty acid concentration was also decreased. Attenuation of the increased vacuolization and Oil Red O staining area was evident on histological examination of liver in ginger-treated rats. However, ginger treatment did not affect chow intake and body weight. Further, ginger treatment suppressed fructose-stimulated overexpression of carbohydrate response element-binding protein (ChREBP) at the mRNA and protein levels in the liver. Consequently, hepatic expression of the ChREBP-targeted lipogenic genes responsible for fatty acid biosynthesis was also downregulated. In contrast, expression of neither peroxisome proliferator-activated receptor- (PPAR-) alpha and its downstream genes, nor PPAR-gamma and sterol regulatory element-binding protein 1c was altered. Thus the present findings suggest that in rats, amelioration of fructose-induced fatty liver and hypertriglyceridemia by ginger treatment involves modulation of the hepatic ChREBP-mediated pathway.
机译:生姜已被证明可以改善脂质紊乱。但是,其潜在的降低甘油三酸酯的机制仍不清楚。果糖的过度消费与肝脏新生脂肪形成的增加有关,从而导致脂质紊乱。在这里,我们发现姜汁的酒精提取物(50μg/ kg /天,每天一次,每天一次口服)的共同给药在5周内逆转了液体果糖引起的大鼠血浆甘油三酸酯和葡萄糖浓度以及肝甘油三酸酯含量的增加。血浆非酯化脂肪酸浓度也降低。在生姜处理的大鼠肝脏的组织学检查中,空泡增加和油红O染色面积的减弱是明显的。但是,生姜治疗并不会影响食物的摄入量和体重。此外,生姜治疗可抑制果糖刺激的肝脏mRNA和蛋白水平上的碳水化合物反应元件结合蛋白(ChREBP)的过表达。因此,负责脂肪酸生物合成的ChREBP靶向脂肪基因的肝表达也被下调。相反,过氧化物酶体增殖物激活的受体-(PPAR-)α及其下游基因,PPAR-γ和固醇调节元件结合蛋白1c的表达均未改变。因此,本发明结果表明,在大鼠中,通过生姜治疗改善果糖诱导的脂肪肝和高甘油三酯血症涉及调节肝ChREBP介导的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号